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Abstract 
The crystal structure of the bovine liver low Mr phosphotyrosine protein phosphatase suggests the involvement of aspartic acid-129 in enzyme 
catalysis. The Asp-129 to alanine mutant has been prepared by oligonucleotide-directed mutagenesis of a synthetic gene coding for the enzyme. The 
purified mutant elicited an highly reduced specific activity (about 0.04% of the activity ofthe wild-type) and a native-like fold, as judged by ~H N M R 
spectroscopy. The kinetic analysis revealed that th  mutant is able to bind the substrate nd a competitive inhibitor, such as inorganic phosphate. 
Moreover, trapping experiments demonstrated it maintains the ability to form the E-P covalent complex. The Asp-129 to alanine mutant shows 
extremely reduced enzyme phosphorylation (k2) nd dephosphorylation (k3)kinetic constant values as compared to the wild-type enzyme. The data
reported indicate that aspartic acid-129 is likely to be involved both in the first step and i  the rate-limiting step of the catalytic mechanism, i.e. the 
nucleophilic attack of the phosphorylated intermediate. 
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1. Introduction 
The low Mr phosphotyrosine protein phosphatase 
(PTPase, recently reviewed in [1]) is a small enzyme pres- 
ent in many vertebrate tissues as two isoforms (type 1 
and 2) whose amino acid sequences differ from each 
other in the 40-73 region. These isoforms have been 
sequenced from varying sources [2~l], and the crystal 
structure of  the bovine liver enzyme (belonging to type 
2) has been recently determined [25]. The low Mr PTPase 
catalyses the hydrolysis of  arylphosphates [5], including 
phosphotyrosine, aswell as of  phosphotyrosine contain- 
ing peptides and proteins [6,7] of  great biological inter- 
est. The low Mr PTPase does not elicit any sequence 
homology to other members of  the PTPase family; 
however, it displays the active-site signature moti f  
CXXXXXR common to all PTPases [8]. The catalytic 
mechanism of the enzyme has been extensively investi- 
gated by chemical modification and oligonucleotide-di- 
rected mutagenesis [8-13]. The substrate hydrolysis pro- 
ceeds in a two-steps reaction mechanism via the forma- 
tion of  a cysteinyl-phosphate intermediate [14] as in the 
case of  all the members of  the PTPase family [15] 
(Scheme 1). The cysteinyl-phosphate intermediate in- 
volves the cysteine residue of  the active-site motif, corre- 
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sponding to Cys-12 in the low M r PTPase [8]. Other 
residues, in particular Arg-18 and Cys-17, have been 
demonstrated to participate to he catalytic mechanism 
[8]. The three-dimensional structure of  the bovine liver 
enzyme has confirmed most of  the previously reported 
data. Furthermore, it has shown the presence of a novel 
residue, Asp-129, in a position suitable for its involve- 
ment in the enzyme catalysis. It has been proposed that 
Asp-129 could act as proton shuttle: in its indissociated 
form, this residue would donate the proton for the re- 
lease of  the tyrosine-OH leaving group and, subse- 
quently, it would perform an activation of  a water mole- 
cule generating the nucleophile responsible for the hy- 
drolysis of  the cysteinyl-phosphate intermediate [25]. In 
the light of  this intriguing hypothesis, we have performed 
an oligonucleotide-directed mutagenesis of  the synthetic 
gene coding for bovine liver low Mr PTPase [16] by re- 
placing aspartate-129 with an alanine residue. The mu- 
tated protein has been purified and studied with regard 
to kinetic behaviour and structural features. 
2. Materials and methods 
2.1. Materials' 
Enzymes: Klenow fragment of DNA polymerase 1 of E. eoli, T4 
DNA ligase, Taq DNA polymerase and restriction enzymes w re ob- 
tained from Promega; Sequenase from USBC and bovine thrombin 
from Sigma. 
k_ 1 k-2 k-3 
E+S ~ ES ~ E-Pi ~ E+P i  
kl k2 k 3 
Scheme 1. 
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Vectors: pMALcPTP is a derivative of pMALc (New England Bio- 
labs), harbouring a chemically synthesized gene coding for bovine liver 
low Mr PTPase [16]; pGEX-KT [17] was a gift of J.E. Dixon. 
Bacterial strains." DH5a E. coli (BRL) was used for mutagenesis and 
TB1 E. coli (New England Biolabs) was used for expression of recom- 
binant fusion protein. 
Oligonucleotides and U.S.E. mutagenesis kit were obtained from 
Pharmacia. Glutathione, glutathione-linked agarose beads, and p-ni- 
trophenylphosphate (PNPP) were from Sigma. Coomassie brilliant blue 
was from BioRad. [a-32p]ATP (800 Ci/mmol) was obtained fron NEN. 
99.8% deuterium oxide and 1,4-dioxane were purchased from Merck. 
All other reagents were analytical grade or the best commercially avail- 
able. Gel radioactivity measurements were made by using a Storage 
Phosphor screen and a Phosphor Imager (Molecular Dynamics). 
2.2. Methods 
Construction of pGEX-KTPTP plasmid: Two synthetic oligonucleo- 
tides (5'-CGCTGAGCAGGTGACCAAGTC-Y and the '-40 forward 
primer' present on the vector) were used in a PCR experiment in the 
presence of pMALcPTP as a template. The resulting fragment, encom- 
passing the entire coding sequence of the bovine liver low Mr PTPase, 
was inserted into the unique restriction site BamHI of the pGEX-KT 
vector, downstream and in frame with the glutathione-S-transferase 
coding sequence. 
Oligonucleotide irected mutagenesis: The unique restriction method 
for site directed mutagenesis [18] with minor modifications, was per- 
formed directly on the pGEX-KTPTP construct. The GAC codon for 
Asp-129 was replaced with the GCC codon for alanine, using a syn- 
thetic mutation target oligonucleotide (5'-TGATCATTGAGGCCCC- 
ATACTATGG-3') and the ApaI restriction site eliminating oligo- 
nucleotide (5'-CGCTGTTAGCAGGTCCATTAAGTTC-3'). The 
presence of the mutation was confirmed by nucleotide sequence 
analysis. 
Expression and purification of recombinant and D129A mutated pro- 
teins: 1 litre of LB broth containing 100 mg/l ampicillin was added to 
10 ml of an overnight culture of a bacterial strain harbouring the 
pGEX-KTPTP or the pGEX-KTPTP-D 129A vectors. The culture was 
incubated at 37°C under continuous shaking until reaching an OD at 
600 nm of 0.4. IPTG was added up to 0.3 mM final concentration, and 
the culture was grown for 2 h. The fusion proteins were then purified 
by affinity chromatography using a glutathione-linked agarose resin, 
equilibrated with a 20 mM 3,3-dimethylglutarate buffer, pH 7.0, con- 
taining 200 mM NaC1, 10 mM 2-mercaptoethanol and 1 mM EDTA. 
The resin was subsequently washed with the equilibrating buffer and 
with a 50 mM Tris-HCl buffer, pH 8.0, containing 10 mM 2-mercap- 
toethanol and 1 mM EDTA. The elution was performed using the latter 
buffer containing 5 mM reduced glutathione. 
Thrombin cleavage. Fusion proteins were incubated with 1:500 (w/w) 
bovine thrombin in 50 mM Tris-HCl buffer, pH 8.0, containing 150 
mM NaCI, 2.5 mM CaC12 and 10 mM 2-mercaptoethanol, f r 1 h at 
room temperature. Cleaved PTPase was purified from glutathione-S- 
transferase and from uncleaved fusion protein by a second affinity 
chromatography on the glutathione-linked resin. 
Equilibrium dialysis experiments: Equilibrium dialysis was performed 
using the apparatus described by Reinard and Jacobsen [19] according 
to the procedure previously reported [8] in the presence of [3:p]inorganic 
phosphate concentrations ranging from 0.3 mM to 2.0 mM (specific 
radioactivity 170 dpm/pmol) and 0.24 mM low Mr PTPase. The radio- 
activity data were subjected to Scatchard analysis. 
Phosphoenzyme trapping." The trapping experiments were performed 
according to Guan and Dixon [15] and to Pot et al. [20]. The methods 
consists in a rapid mixing of 2/tl  (10/lg) of enzyme with 18 ,ul of 20 
mM 32P-labeled benzoylphosphate (specific radioactivity 9450 dpm/ 
pmol) synthesized according to Cirri et al. [8], followed by an addition 
of 20/tl of Laemmli SDS-PAGE sample buffer containing 4% SDS. The 
trapped sample was then analysed by SDS-PAGE according to 
Laemmli [21] without heating. 32p-Labeled proteins were visualized by 
autoradiography. 
Protein concentration determination: Protein concentration was de- 
termined by Coomassie brilliant blue assay. 
Enzyme activity measurements: The low M r PTPase activity was 
measured by following the p-nitrophenol release at 37°C in 0.1 M 
acetate buffer, pH 5.5, containing 1 mM EDTA, from PNPP as a 
substrate (g40o --- 18,000 M-~.cm -') in alkaline solution, according to 
Heinrikson [22]. The Dl29A mutant activity was measured at  final 
enzyme concentration f 0.025 mg/ml. All kinetic parameters eported 
in Table 1 were calculated as described in [8]. 
NMR analysis: Protein concentration of the sample used for ~H 
NMR spectroscopy measurements was 0.5 mM. The samples were 
prepared by 5 concentration/dilution cycles in Centricon-10 microcon- 
centrators (Amicon) in 150 mM d3-acetate/D20 buffer at pH 5.5. ~H 
NMR one dimensional spectra were recorded at 600 MHz and 25°C 
on a Bruker AMX600 spectrometer, using a sweep width of 7463 Hz 
and 16k data points. The residual water resonance was suppressed by 
a selective pulse during the relaxation delay (2.0 s). Prior to Fourier 
transformation the free-induction decays were zero-filled to 32k data 
points, and a signal-to-noise ratio enhancing exponential multiplication 
(line broadening of 4 Hz) was applied. 1,4-dioxan was used as an 
internal shift reference at 3.74 ppm. 
3. Results 
A PCR amplification was performed on the 
pMALcPTP construct [9] in order to subclone in the 
pGEX-KT vector the entire polynucleotide sequence 
coding for the wild-type low M r bovine liver PTPase. 
Clones with the correct insertion of the gene were 
screened by hybridisation and completely checked by 
sequencing with the Sanger method. The vector pGEX- 
KT was able to easily produce an heterologous polypep- 
tide in E. coli as a fusion protein where the carboxyl- 
terminus of the glutathione-S-transferase was linked to 
the recombinant PTPase amino-terminus. A thrombin 
recognition site was present at the joining point of the 
chimeric protein, pGEX-KT contained a glycine kinker 
[17] just before the thrombin cleavage site: this insertion 
dramatically improved the fusion protein cleavage rate. 
In vitro oligonucleotide-directed mutagenesis was per- 
formed on the pGEX-KToPTP construct in order to re- 
place Asp-129 by an alanine residue (see under section 
2). The presence of the mutation was confirmed by DNA 
sequencing according to Sanger. 
Both the wild-type recombinant and the D129A mu- 
tant enzymes were cleaved in a yield of about 70% after 
1 h treatment in the presence of thrombin. The subse- 
kDa A B C 
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Fig. 1. SDS-PAGE of the purified recombinant low Mr PTPases. Lane 
A: Mr markers; lane B: wild-type nzyme; lane C: D129A mutant. 
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Fig. 2. Scatchard plot determined from the equilibrium dialysis experi- 
ment in the presence of (32p) inorganic phosphate. O, wild-type recom- 
binant low Mr PTPase; O, D129A mutant. The Kd values were 0.5 mM 
and 1.7 mM, respectively. 
quent purification enabled us to obtain at least 8 mg of 
pure proteins per liter of culture. Fig. 1 shows the SDS- 
PAGE of the purified protein. It can be seen that the 
mutant was obtained with a good purity and a molecular 
weight corresponding to that of the wild-type recombi- 
nant enzyme. The purified mutant was subjected to ki- 
netic analysis. The main kinetic parameters are summa- 
rized in Table 1. The D129A mutant exhibits an ex- 
tremely reduced specific activity (less than 0.04%) as 
compared to the wild-type enzyme. For this reason the 
activity assays were performed by adding to the assay 
mixture an amount of enzyme over one hundred times 
higher than that usually used for the wild-type enzyme 
assay. In order to assess whether the reduced specific 
activity of the D 129A mutant was due to the loss of the 
ability to bind the substrate or to an impaired catalytic 
mechanism, the affinity of the mutant enzyme for both 
PNPP and inorganic phosphate was determined. The 
apparent Km of the DI29A mutant using PNPP as a 
substrate was 66 pM, about three times lower as com- 
pared to that of the wild-type recombinant enzyme (190 
~tM). The substrate affinity of the mutant enzyme was 
Table 1 
Main kinetic parameters for recombinant wild-type and D129A mu- 
tated low Mr PTPase, as calculated in 100 mM acetate buffer, pH 5.5, 
in the presence of 1 mM EDTA at 37°C ~ 
gm kcat Ks k 2 k3 
(mM) (s -I) (mM) (s -1) (s -t) 
Wild-type 0.19 30.0 5.0 789.5 31.2 
D129A 0.066 0.011 1.7 0.294 0.012 
a Using PNPP as a substrate. 
also determined by a non-kinetic approach. An equilib- 
rium dialysis experiment was therefore carried out using 
[32P]inorganic phosphate, a well known competitive in- 
hibitor of the enzyme. The radioactivity values obtained 
for both the D 129A mutant and the wild-type recombi- 
nant enzyme were processed by Scatchard analysis. Fig. 
2 reports the Scatchard plot so obtained, resulting in a 
Kd for inorganic phosphate of about 1.7 mM. This value 
is only three times higher than that calculated for the 
wild-type recombinant enzyme (0.5 mM), demonstrating 
that the mutant enzyme is still able to efficiently bind the 
substrate. 
The catalytic pathway for the D129A mutant enzyme 
was investigated particularly by looking for the possible 
presence of the cysteinylphosphate intermediate demon- 
strated for the wild-type enzyme. Trapping experiments 
were performed using [32p]benzoylphosphate, one of the 
enzyme substrates which was previously found to be 
hydrolysed by a mechanism involving the cysteinyl- 
phosphate intermediate formation [8]. Fig. 3 shows the 
autoradiography of the SDS-PAGE after the trapping 
experiment carried out on the D129A mutant and the 
recombinant wild-type nzymes. The radioactivity of the 
spot relative to the D129A mutant was over 30-fold as 
compared to that corresponding to the recombinant 
wild-type enzyme. A compared kinetic analysis was car- 
ried out in order to assess the effectiveness of phosphoin- 
termediate accumulation and to calculate the K s value for 
PNPP of both the D129A mutant and the recombinant 
wild-type enzyme. The kinetic analysis was performed 
according to the approach reported elsewhere [8] by in- 
vestigating the transphosphorylation activity of the mu- 
tant and wild-type enzymes versus glycerol using PNPP 
as a substrate. Table 1 summarizes the results obtained. 
Both the enzymes elicit similar K s values indicating that 
their true affinities for the substrate are nearly the same. 
The ratio of the kcat values is about 3,000, in agreement 
A B 
18 kDa 
Fig. 3. Autoradiography of the SDS-PAGE relative to the phosphoen- 
zyme trapping experiment. Lane A: wild-type recombinant low M r 
PTPase; lane B: D129A mutant. 
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Fig. 4. Aromatic and aliphatic regions of the 600 MHz 1H NMR spectra of the recombinant PTPase. A: wild-type enzyme; B:DI29A mutant. 
with the low specific activity of the D129A mutant. Fur- 
thermore, the D 129A mutant elicits rate constants of the 
phosphointermediate formation (k2) and hydrolysis (k3) 
which are significantly ower with respect to those of the 
wild-type nzyme. In particular, the k2 and k3 ratios of 
the two enzymes are about 2,500 and 3,000, respectively, 
indicating that the lack of Asp-129 slows down both the 
formation and the hydrolysis of the phosphointermedi- 
ate. Finally, the data reported in Table 1 indicate that the 
radioactivity spot found in the phosphoenzyme trapping 
experiments for the D129A mutant is likely to be due to 
its extremely reduced k 3 value. Under these xperimental 
conditions, the time needed for SDS enzyme denatura- 
tion is not large enough to allow a significant nucleo- 
philic attack of water to the phosphointermediate. I  
results that the fraction of E-P complex blocked by the 
trapping experiments i  higher in the D129A mutant 
than in the wild-type nzyme, as it has been effectively 
found. This is further confirmed by the values of the k2/k3 
ratios relative to the D129A mutant and the wild-type 
enzymes (24.7 and 25.3, respectively), indicating very 
similar steady-state levels of phosphointermediate. 
To exclude the possibility that the sharp loss of activity 
of the D129A mutant was due to major conformational 
changes of the enzyme structure, an ~H NMR spectros- 
copy study was done. Fig. 4 reports the 600 MHz ]H 
NMR spectra of the D 129A mutant and the recombinant 
wild-type nzymes. Both spectra are characterised by an 
extensive chemical shift dispersion in the aromatic as 
well as in the aliphatic proton regions. This finding is a 
consequence ofpersistent contacts in the enzyme three- 
dimensional structure, indicating the existence of a well- 
constrained fold typical of a native protein [23]. Further- 
more, the ~H NMR spectra are very similar to each 
other, except for some minor differences in the backbone 
amide proton region (~7.5-10.0 ppm). These differences, 
arising from a variable extent of proton exchange with 
the deuterated solvent during the sample preparation, do 
not account for a significant modification i the overall 
structure. The 1H NMR spectrum of the wild-type re- 
combinant protein is very similar to previously reported 
spectra of a corresponding protein from bovine heart 
[12,13]. 
4. Discussion 
The possible involvement of Asp129 in the catalytic 
mechanism ofthe low Mr PTPase, suggested by the crys- 
tal structure of the enzyme, has been studied by oligonu- 
cleotide-directed mutagenesis. The kinetic, substrate af- 
finity, and NMR data resulting from the experiments 
indicate that the D129A mutant elicits an extremely re- 
duced activity, though maintaining a native-like struc- 
ture and a good affinity for both inorganic phosphate, 
a competitive inhibitor, and PNPP, an enzyme substrate. 
On the other hand, the trapping experiments result 
shows that the D129A mutant apparently accumulates 
332 
the cysteinylphosphate intermediate formed in the reac- 
tion mechanism. The kinetic analysis indicates that the 
D129A mutant elicits very reduced k2 and k 3 values, 
whereas the k Jk  3 ratios of  the two enzymes are nearly 
identical to each other, revealing a similar phosphointer- 
mediate steady-state l vel. This data indicates that the 
phosphoenzyme accumulation i  the D129A mutant, as 
revealed by the trapping experiments, can be ascribed to 
the low k 3 value and hence to a reduced susceptibility of  
the phosphoenzyme to hydrolysis during the SDS de- 
naturation. It has previously been demonstrated that the 
cysteinylphosphate hydrolysis is the rate-limiting step, 
for most substrates, in the overall catalytic process of  the 
low M r PTPase [5]. The dramatically reduced specific 
activity of  the D 129A mutant is consistent with the par- 
ticipation of  Asp-129 to the catalysis rate-limiting step, 
supporting the involvement of  such residue in the cys- 
teinylphosphate nucleophilic attack suggested by the 
crystal structural data [25]. However, the kinetic analysis 
supports an involvement of  Asp-129 in the phosphoin- 
termediate formation, as indicated by the value of  the k2, 
which is about 2500-fold lower in the D129A mutant as 
compared to the wild-type enzyme. The reduced k2 value 
of  the D129A mutant agrees with the hypothesis of  an 
involvement of  Asp-129 in its indissociated form as an 
electrophile in the release of  the phenolic leaving group 
during the formation of  E-P covalent complex. Such 
results confirms the hypothesis of  a double role of  Asp- 
129 in enzyme catalysis. 
This conclusion is further supported by the 1H NMR 
data, allowing to exclude the presence of  any major con- 
formational change in the D129A mutant, whose spec- 
trum in almost identical to that of  the recombinant wild- 
type enzyme. However, local structural changes at the 
active site due to the replacement of  an acidic residue by 
an hydrophobic one, cannot be excluded. It follows that 
the slight differences in substrate affinity between the 
D129A mutant and the recombinant wild-type enzyme 
could be the consequence of such minor conformational 
changes involving the active site region. Nevertheless, 
this possibility does not contradict our conclusion about 
the double role of  Asp-129 in enzyme catalysis. Further 
X-ray experiments on the D129A mutant are necessary 
to address the existence of such active site modifications 
and to further confirm the involvement of  Asp- 129 in the 
phosphointermediate formation. Recently, the presence 
of  an Asp residue in the active site region of  the Yersinia 
enterocolitica PTPase, a member of  the soluble PTPases 
subfamily, has been suggested on the basis of  a site- 
directed mutagenesis study [24]. These authors propose 
that this residue is likely to act as a general acid in the 
enzyme catalytic mechanism. Our data are in agreement 
with these findings further supporting the role of  an Asp 
residue in the mechanism of  the reaction catalysed by 
soluble PTPases. 
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